Sanofi expects its RSV antibody jointly developed with AstraZeneca will be available next season, executive VP of vaccines ...
Plant-based Covid-19 vaccine developer Medicago shut down this week with little fanfare. And its two subsidiaries, Medicago R ...
Senate Finance Chair Ron Wyden (D-OR) this week sent a letter to the head of the Centers for Medicare & Medicaid Services ...
Eisai will eliminate 91 after it out-licensed a seizure drug. An Eisai spokesperson told Endpoints News that the change-up is ...
Following in AbbVie’s footsteps, Teva confirmed on Friday that it’s dropping out of the industry trade group Pharmaceutical ...
What if you could “see” the emotions and feelings of people living with metastatic breast cancer? That's what Gilead Sciences ...
Months after the FDA placed Phase III trials of Sanofi’s BTK inhibitor on hold, the company is winding down one of the ...
Regeneron faced a substantial slump in overall revenue last year, but the focus still remains on some of its biggest ...
GSK has secured the first of four US approvals it’s hoping for this year, as the FDA greenlit daprodustat as a treatment for ...
Roche announced another leadership shuffle Thursday morning – the head of global product strategy, Teresa Graham, will take ...
After 13 years as president and COO at Optinose, Ramy Mahmoud has stepped into a new role as its CEO. He is taking the place ...
Gilead surpassed Wall Street and analyst expectations for Q4 earnings. Company leaders said Thursday that Gilead is in a ...